Clinical trials
Phase 1 Anemia, Refractory, with Excess of Blasts trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 7 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
| Terminated | 13 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| Fred Hutchinson Cancer Center | 6 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 6 |
| Memorial Sloan Kettering Cancer Center | 4 |
| M.D. Anderson Cancer Center | 3 |
| Vion Pharmaceuticals | 3 |
| Case Comprehensive Cancer Center | 2 |
| Dana-Farber Cancer Institute | 2 |
| Massachusetts General Hospital | 2 |
| University Health Network, Toronto | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 67 |
| Leukemia, Myeloid, Acute | 43 |
| Leukemia | 34 |
| Myelodysplastic Syndromes | 33 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 32 |
| Leukemia, Myelomonocytic, Chronic | 29 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 21 |
| Blast Crisis | 19 |
| Congenital Abnormalities | 19 |
| Myeloproliferative Disorders | 17 |
Trials
Showing 76 to 67 of 67. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.